40 related articles for article (PubMed ID: 27405551)
1. Activity of Cu2Zn2 superoxide dismutase against the human immunodeficiency virus type 1.
Miesel R; Mahmood N; Weser U
Redox Rep; 1995 Feb; 1(2):99-103. PubMed ID: 27405551
[TBL] [Abstract][Full Text] [Related]
2. Lecithinized superoxide dismutase: an inhibitor of human immunodeficiency virus replication.
Premanathan M; Nakashima H; Igarashi R; Mizushima Y; Yamada K
AIDS Res Hum Retroviruses; 1997 Mar; 13(4):283-90. PubMed ID: 9071427
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
[TBL] [Abstract][Full Text] [Related]
4. In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV.
Hazen R; Harvey R; Ferris R; Craig C; Yates P; Griffin P; Miller J; Kaldor I; Ray J; Samano V; Furfine E; Spaltenstein A; Hale M; Tung R; St Clair M; Hanlon M; Boone L
Antimicrob Agents Chemother; 2007 Sep; 51(9):3147-54. PubMed ID: 17620375
[TBL] [Abstract][Full Text] [Related]
5. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis.
Witvrouw M; Pannecouque C; Switzer WM; Folks TM; De Clercq E; Heneine W
Antivir Ther; 2004 Feb; 9(1):57-65. PubMed ID: 15040537
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of DAPY-DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Wu HQ; Yao J; He QQ; Chen WX; Chen FE; Pannecouque C; De Clercq E; Daelemans D
Bioorg Med Chem; 2015 Feb; 23(3):624-31. PubMed ID: 25537532
[TBL] [Abstract][Full Text] [Related]
8. Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infection.
Sastry JK; Nehete PN; Khan S; Nowak BJ; Plunkett W; Arlinghaus RB; Farquhar D
Mol Pharmacol; 1992 Mar; 41(3):441-5. PubMed ID: 1372082
[TBL] [Abstract][Full Text] [Related]
9. Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion.
Takami Y; Ito M; Baba M; Ikuta K; Tanabe F; Shigeta S
Fukushima J Med Sci; 1999 Jun; 45(1):13-24. PubMed ID: 10748552
[TBL] [Abstract][Full Text] [Related]
10. TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1.
Andries K; Azijn H; Thielemans T; Ludovici D; Kukla M; Heeres J; Janssen P; De Corte B; Vingerhoets J; Pauwels R; de Béthune MP
Antimicrob Agents Chemother; 2004 Dec; 48(12):4680-6. PubMed ID: 15561844
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
12. Syncytium formation and destruction of bystander CD4+ cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry.
Schols D; Pauwels R; Baba M; Desmyter J; De Clercq E
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2397-408. PubMed ID: 2789268
[TBL] [Abstract][Full Text] [Related]
13. Topical transduction of superoxide dismutase mediated by HIV-1 Tat protein transduction domain ameliorates 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice.
Song HY; Lee JA; Ju SM; Yoo KY; Won MH; Kwon HJ; Eum WS; Jang SH; Choi SY; Park J
Biochem Pharmacol; 2008 Mar; 75(6):1348-57. PubMed ID: 18164693
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-HIV activity of aryl-2-[(4-cyanophenyl)amino]-4-pyrimidinone hydrazones as potent non-nucleoside reverse transcriptase inhibitors.
Ma XD; Yang SQ; Gu SX; He QQ; Chen FE; De Clercq E; Balzarini J; Pannecouque C
ChemMedChem; 2011 Dec; 6(12):2225-32. PubMed ID: 21990112
[TBL] [Abstract][Full Text] [Related]
15. Identification of three mutations in the Cu,Zn-superoxide dismutase (Cu,Zn-SOD) gene with familial amyotrophic lateral sclerosis: transduction of human Cu,Zn-SOD into PC12 cells by HIV-1 TAT protein basic domain.
Chou CM; Huang CJ; Shih CM; Chen YP; Liu TP; Chen CT
Ann N Y Acad Sci; 2005 May; 1042():303-13. PubMed ID: 15965076
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors.
Cushman M; Golebiewski WM; Graham L; Turpin JA; Rice WG; Fliakas-Boltz V; Buckheit RW
J Med Chem; 1996 Aug; 39(16):3217-27. PubMed ID: 8759644
[TBL] [Abstract][Full Text] [Related]
18. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.
Cinatl J; Cinatl J; Weber B; Rabenau H; Weissflog A; Mainke M; Kornhuber B; Doerr HW
Acta Virol; 1993 Oct; 37(5):360-8. PubMed ID: 8184788
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant and anti-inflammatory properties of a Cucumis melo LC. extract rich in superoxide dismutase activity.
Vouldoukis I; Lacan D; Kamate C; Coste P; Calenda A; Mazier D; Conti M; Dugas B
J Ethnopharmacol; 2004 Sep; 94(1):67-75. PubMed ID: 15261965
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1.
Currens MJ; Gulakowski RJ; Mariner JM; Moran RA; Buckheit RW; Gustafson KR; McMahon JB; Boyd MR
J Pharmacol Exp Ther; 1996 Nov; 279(2):645-51. PubMed ID: 8930167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
